Mixed-Cell Type Choroidal Melanoma in a Middle-Aged Woman

Authors

DOI:

https://doi.org/10.32635/2176-9745.RBC.2023v69n2.3890

Keywords:

choroid neoplasms, melanoma, eye enucleation, eye pain

Abstract

Introduction: Melanomas are malignant neoplasms that occur in various anatomical sites, including the eye. Ocular melanomas account for 5% of all melanomas and are mainly described in Caucasian and older individuals. This study describes the clinical and pathological characteristics of uveal (choroid) melanoma in a Caucasian patient. Case report: A 41-year-old Caucasian female patient, brown eyes, without history of ophthalmological diseases or family history of cancer experienced pain and loss of visual acuity in the left eye. On clinical examination, an increase of ocular pressure was detected. Ultrasound showed a mushroom-like neoformation. Moreover, magnetic resonance imaging showed a mass with spontaneous hypersignal on T1-weighted images, intense gadolinium enhancement, and marked hyposignal on T2-weighted images. The patient was referred to the Oncology Ophthalmology department for enucleation due to suspected uveal melanoma. Anatomopathological analysis revealed a blackened mass in the eyeball. Histologically, the mass comprised spindle cells (50%) and epithelioid cells (50%). A diagnosis of choroidal melanoma was established based on the identification of ophthalmoscopic, imaging, and histological characteristics of the tumor. Conclusion: Choroidal melanomas usually occur in males, clear-eyed, and older individuals. A wide variety of ocular lesions may mimic choroidal melanoma, which should be included in the differential diagnosis of choroidal nevus and peripheral hemorrhages.

Downloads

Download data is not yet available.

References

Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond). 2017;31(2):241-57. doi: https://doi.org/10.1038/eye.2016.275 DOI: https://doi.org/10.1038/eye.2016.275

Branisteanu DC, Bogdanici CM, Branisteanu DE, et al. Uveal melanoma diagnosis and current treatment options (Review). Exp Ther Med. 2021;22(6):1428. doi: https://doi.org/10.3892/etm.2021.10863 DOI: https://doi.org/10.3892/etm.2021.10863

Calabria AC, Kempfer AV, Omizzolo JAE, et al. Melanomas primários de órbita: uma revisão narrativa da literatura. Soc Development. 2021;10(16): e103101623682. doi: https://doi.org/10.33448/rsd-v10i17.23682 DOI: https://doi.org/10.33448/rsd-v10i17.23682

Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci. 2021;22(12):6395. doi: https://doi.org/10.3390/ijms22126395 DOI: https://doi.org/10.3390/ijms22126395

Lange MJ, Razzaq L, Versluis M, et al. Distribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanism. PLoS One. 2015;10(9):e0138002. doi: https://doi.org/10.1371/journal.pone.0138002 DOI: https://doi.org/10.1371/journal.pone.0138002

Khan J, Damato BE. Accuracy of choroidal melanoma diagnosis by general ophthalmologists: a prospective study. Eye (Lond). 2007;21(5):595-7. doi: https://doi.org/10.1038/sj.eye.6702276 DOI: https://doi.org/10.1038/sj.eye.6702276

Tara S, Prabu R, Muralidhar V. Congenital uveal malignant melanoma- A rare case report. Am J Ophthalmol Case Rep. 2022;26:101539. doi: https://doi.org/10.1016/j.ajoc.2022.101539 DOI: https://doi.org/10.1016/j.ajoc.2022.101539

Foti PV, Inì C, Broggi G, et al. Histopathologic and MR imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: initial results. Cancers (Basel). 2022;14(1):215. doi: https://doi.org/10.3390/cancers14010215 DOI: https://doi.org/10.3390/cancers14010215

Broggi G, Russo A, Reibaldi M, et al. Histopathology and genetic biomarkers of choroidal melanoma. Appl Sci. 2020;10(22):8081. doi: https://doi.org/10.3390/app10228081 DOI: https://doi.org/10.3390/app10228081

Chalada M, Ramlogan-Steel CA, Dhungel BP, et al. The impact of ultraviolet radiation on the aetiology and development of uveal melanoma. Cancers (Basel). 2021;13(7):1700. doi: https://doi.org/10.3390/cancers13071700 DOI: https://doi.org/10.3390/cancers13071700

Virgili G, Gatta G, Ciccolallo L, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114(12):2309-15. doi: https://doi.org/10.1016/j.ophtha.2007.01.032 DOI: https://doi.org/10.1016/j.ophtha.2007.01.032

Lucena E, Goldemberg DC, Thuler LCS, et al. Epidemiology of uveal melanoma in Brazil. Int J Retina Vitreous. 2020;6(1):51. doi: https://doi.org/10.1186/s40942-020-00261-w DOI: https://doi.org/10.1186/s40942-020-00261-w

Shields CL, Manalac J, Das C, et al. Choroidal melanoma: clinical features, classification, and top 10 pseudomelanomas. Curr Opin Ophthalmol. 2014;25(3):177-85. doi: https://doi.org/10.1097/ICU.0000000000000041 DOI: https://doi.org/10.1097/ICU.0000000000000041

Kaliki S, Shields CL, Shields JA. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015;63(2):93-102. doi: https://doi.org/10.4103/0301-4738.154367 DOI: https://doi.org/10.4103/0301-4738.154367

Fernandes BF, Odashiro AN, Saraiva VS, et al. Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma. J Carcinog. 2007;6:6. doi: https://doi.org/10.1186/1477-3163-6-6 DOI: https://doi.org/10.1186/1477-3163-6-6

Iwamoto S, Burrows RC, Kalina RE, et al. Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol. 2002;120(4):466-70. doi: https://doi.org/10.1001/archopht.120.4.466 DOI: https://doi.org/10.1001/archopht.120.4.466

Downloads

Published

2023-05-12

How to Cite

1.
Frinhani MAN, Pestana RA, Dantas GSB, Bastianello MA, Ferreira F de CE, Altoé KC, Franzin MG, Marcolongo-Pereira C, Chiarelli-Neto O. Mixed-Cell Type Choroidal Melanoma in a Middle-Aged Woman. Rev. Bras. Cancerol. [Internet]. 2023 May 12 [cited 2024 Jul. 3];69(2):e-203890. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3890

Issue

Section

CASE REPORT